Advertisement
Canada markets close in 4 hours 55 minutes

  • S&P/TSX

    23,788.45
    -77.82 (-0.33%)
     

  • S&P 500

    5,684.18
    -29.46 (-0.52%)
     

  • DOW

    41,941.97
    -83.22 (-0.20%)
     

  • CAD/USD

    0.7366
    -0.0011 (-0.15%)
     

  • CRUDE OIL

    71.78
    -0.17 (-0.24%)
     

  • Bitcoin CAD

    85,358.54
    -172.48 (-0.20%)
     

  • XRP CAD

    0.79
    -0.01 (-1.17%)
     

  • GOLD FUTURES

    2,640.60
    +26.00 (+0.99%)
     

  • RUSSELL 2000

    2,241.84
    -10.86 (-0.48%)
     

  • 10-Yr Bond

    3.7550
    +0.0150 (+0.40%)
     

  • NASDAQ

    17,892.43
    -121.55 (-0.67%)
     

  • VOLATILITY

    16.00
    -0.33 (-2.02%)
     

  • FTSE

    8,233.71
    -95.01 (-1.14%)
     

  • NIKKEI 225

    37,723.91
    +568.58 (+1.53%)
     

  • CAD/EUR

    0.6608
    +0.0003 (+0.05%)
     
MARKETS LIVE BLOG:

STOCKS PULL BACK FROM RECORD HIGHS AS FED CHEER FIZZLES

FedEx shares down 14% as company's lowered outlook offers warning sign for economy

Stocks in play: InnoCan Pharma Corp

Baystreet.ca

Announces the launch of its licensing and commercialization strategy work with respect to cannabinoid (CBD) therapy in the veterinary field. The appointment of a dedicated internal team will foster engagement between Innocan and prospective clients in the veterinary field in order to explore potential collaborations and commercialization opportunities. Innocan's innovative CBD-based products have previously demonstrated promise in human clinical trials, InnoCan Pharma Corp shares C.INNO are trading unchanged at $0.25.

Read: